ZOLL MEDICAL CORPORATION
SC 13D/A, 1999-07-20
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: PUTNAM TAX FREE HEALTH CARE FUND, N-30D, 1999-07-20
Next: MEDICAL INDUSTRIES OF AMERICA INC, 8-K, 1999-07-20



                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                  SCHEDULE 13D
                    Under the Securities Exchange Act of 1934

  INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND
               AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a)

                               (Amendment No. 15)*

Zoll Medical Corporation
(Name of Issuer)

Common Stock, $.02 par value
(Title of Class of Securities)

989922109
(CUSIP Number)

Stephen M. Schultz, Esq., Kleinberg, Kaplan, Wolff & Cohen, P.C., 551 Fifth
Avenue, New York, New York 10176
Tel: (212) 986-6000
(Name, Address and Telephone Number of Person Authorized to Receive Notices and
Communications)

July 14, 1999
(Date of Event which Requires Filing of this Statement)

If the filing person has previously  filed a statement on Schedule 13G to report
the  acquisition  which is the subject of this  Schedule 13D, and is filing this
schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box
[ ].

Note:  Schedules  filed in paper format shall include a signed original and five
copies of the  schedule,  including  all  exhibits.  See Rule 13d-7(b) for other
parties to whom copies are to be sent.

*The  remainder of this cover page shall be filled out for a reporting  person's
initial filing on this form with respect to the subject class of securities, and
for  any  subsequent   amendment   containing   information  which  would  alter
disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the  Securities  Exchange  Act of
1934 ("Act") or otherwise  subject to the liabilities of that section of the Act
but  shall be  subject  to all other  provisions  of the Act  (however,  see the
Notes).

                       (Continued on the following pages)

                                  (Page 1 of 7)


<PAGE>


                                  SCHEDULE 13D

Page 7 of 7

1.       NAME OF REPORTING PERSONS
         I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
                  Elliott Associates, L.P., a Delaware Limited Partnership

2.       CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
         (a)[x]
         (b)[ ]

3.       SEC USE ONLY

4.       SOURCE OF FUNDS*
                  00

5.       CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
          ITEMS 2(d) or 2(e)  [  ]

6.       CITIZENSHIP OR PLACE OF ORGANIZATION
                  Delaware

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH

7.       SOLE VOTING POWER
                  165,900

8        SHARED VOTING POWER
                  0

9.       SOLE DISPOSITIVE POWER
                  165,900

10.      SHARED DISPOSITIVE POWER
                  0

11.      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
                  165,900

12.      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11)
         EXCLUDES CERTAIN SHARES*   [ ]

13.      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
                  2.66%

14.      TYPE OF REPORTING PERSON*
                  PN

                      *SEE INSTRUCTIONS BEFORE FILLING OUT!


<PAGE>


1.       NAME OF REPORTING PERSONS
         I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
                  Westgate International, L.P., a Cayman Islands Limited
                     Partnership

2.       CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
         (a)[x]
         (b)[ ]

3.       SEC USE ONLY

4.       SOURCE OF FUNDS*
                  00

5.       CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS
         REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)     [ ]

6.       CITIZENSHIP OR PLACE OF ORGANIZATION
                  Cayman Islands, British West Indies

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH

7.       SOLE VOTING POWER
                  0

8.       SHARED VOTING POWER
                  164,100

9.       SOLE DISPOSITIVE POWER
                  0

10.      SHARED DISPOSITIVE POWER
                  164,100

11.      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH
         REPORTING PERSON
                  164,100

12.      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11)
         EXCLUDES CERTAIN SHARES*           [ ]

13.      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
                  2.63%

14.      TYPE OF REPORTING PERSON*
                  PN

                      *SEE INSTRUCTIONS BEFORE FILLING OUT!


<PAGE>


1.       NAME OF REPORTING PERSONS
         I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
                  Martley International, Inc., a Delaware corporation

2.       CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
         (a)[x]
         (b)[ ]

3.       SEC USE ONLY

4.       SOURCE OF FUNDS*
                  00

5.       CHECK BOX IF DISCLOSURE OF LEGAL  PROCEEDINGS  IS REQUIRED  PURSUANT
           TO ITEMS 2(d) or 2(e)           [ ]

6.       CITIZENSHIP OR PLACE OF ORGANIZATION
                  Delaware

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH
REPORTING PERSON WITH

7.       SOLE VOTING POWER
                  0

8.       SHARED VOTING POWER
                  164,100

9.       SOLE DISPOSITIVE POWER
                  0

10.      SHARED DISPOSITIVE POWER
                  164,100

11.      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH
         REPORTING PERSON
                  164,100

12.      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11)
         EXCLUDES CERTAIN SHARES*           [ ]

13.      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
                  2.63%

14.      TYPE OF REPORTING PERSON*
                  CO

                      *SEE INSTRUCTIONS BEFORE FILLING OUT!


<PAGE>


         This  statement is filed  pursuant to Rule 13d-2(a) with respect to the
shares of common  stock,  $.02 par value (the  "Common  Stock") of Zoll  Medical
Corporation (the "Issuer") beneficially owned by the Reporting Persons specified
herein as of July 19, 1999 and amends and  supplements  the  Schedule  13D dated
January 8, 1998,  as amended on January 23, 1998,  February 20, 1998,  April 17,
1998, May 11, 1998, May 26, 1998, August 3, 1998,  September 10, 1998,  November
13,  1998,  January 7, 1999,  January 28, 1999,  March 5, 1999,  March 18, 1999,
March 29,  1999 and April 30,  1999 (the  "Schedule  13D").  Except as set forth
herein, the Schedule 13D, as previously amended, is unmodified.

ITEM 3.  Source and Amount of Funds or Other Consideration

         The source and amount of funds used by Elliott in making its  purchases
of the shares of Common Stock beneficially owned by it are set forth below:

SOURCE OF FUNDS                                      AMOUNT OF FUNDS
Margin accounts maintained at                        $1,174,835.71
Goldman Sachs, Smith Barney,
Merrill Lynch and Paine Webber

         The source and amount of funds used by Westgate in making its purchases
of the shares of Common Stock beneficially owned by it are set forth below:

SOURCE OF FUNDS                                      AMOUNT OF FUNDS
Margin accounts maintained at                        $1,090,151.70
Goldman Sachs, Smith Barney
and Paine Webber

ITEM 5.  Interest in Securities of the Issuer

         (a)  Elliott   beneficially   owns  165,900   shares  of  Common  Stock
constituting 2.66% of the outstanding shares of Common Stock.

         Westgate  beneficially owns 164,100 shares of Common Stock constituting
2.63% of the outstanding shares of Common Stock.

         Together,  Elliott and  Westgate  beneficially  own  330,000  shares of
Common Stock constituting 5.30% of the outstanding shares of Common Stock.


<PAGE>


         (b) Elliott has the power to vote or direct the vote of, and to dispose
or direct the disposition of, the shares of Common Stock  beneficially  owned by
it.

         Westgate  has the shared  power with Martley to vote or direct the vote
of,  and to dispose or direct  the  disposition  of, the shares of Common  Stock
owned by  Westgate.  Information  regarding  each of Westgate and Martley is set
forth in Item 2 of this Schedule 13D and is expressly  incorporated by reference
herein.

         (c) The following transactions were effected by Elliott during the past
sixty (60) days:

                                   Approx. Price per
                  Amount of Shs.   Share (excl. of
Date     Security Bought (Sold)    commissions)

5/12/99  Common    (2,000)          $12.6250
5/28/99  Common   (10,000)          $12.5000
7/13/99  Common   (10,000)          $12.4031
7/14/99  Common   (10,000)          $12.6563


         The above transactions were effected by Elliott on NASDAQ in New York.

         The following  transactions  were effected by Westgate  during the past
sixty (60) days:

                                   Approx. Price per
                  Amount of Shs.   Share (excl. of
Date     Security Bought (Sold)    commissions)

5/12/99  Common    (2,000)          $12.6250
5/28/99  Common   (11,500)          $12.5000
7/13/99  Common   (10,000)          $12.4031
7/14/99  Common   (10,000)          $12.6563

         The above transactions were effected by Westgate on NASDAQ in New York.

         No other  transactions  that  have not been  previously  reported  were
effected by either Elliott or Westgate during the past sixty (60) days.


<PAGE>



         (d) No person  other than Elliott has the right to receive or the power
to direct the receipt of dividends  from,  or the proceeds from the sale of, the
shares of Common Stock beneficially owned by Elliott.

         No person other than  Westgate has the right to receive or the power to
direct the receipt of  dividends  from,  or the  proceeds  from the sale of, the
shares of Common Stock beneficially owned by Westgate and Martley.

         (e)      Not applicable.


                                   SIGNATURES

         After  reasonable  inquiry and to the best of its knowledge and belief,
the undersigned each certifies that the information with respect to it set forth
in this statement is true, complete and correct.

Dated:
July 19, 1999              ELLIOTT ASSOCIATES, L.P.

                                    By:  Braxton Associates, L.P.,
                                            as General Partner

                                    By:  Braxton Associates, Inc.,
                                            as General Partner

                                            By: /s/ Elliot Greenberg
                                                     Elliot Greenberg
                                                     Vice President

                                    WESTGATE INTERNATIONAL, L.P.

                                    By: Martley International, Inc.,
                                            as attorney-in-fact


                                            By: /s/ Elliot Greenberg
                                                     Elliot Greenberg
                                                     Vice President


                                    MARTLEY INTERNATIONAL, INC.


                            By: /s/ Elliot Greenberg
                                            Elliot Greenberg
                                            Vice President



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission